Cutting-edge Titan-1 platform powers complete ‘sample to answer’ services for pharma, biotech and research partners and clients, delivering response prediction, biomarker identification, and unprecedented insights into the role of the bacterial microbiome for any study or trial.

The powerful platform can also support commercial laboratories wanting to offer large scale microbiome testing, pathogen identification and tracking, and multiple other services – for both clinical and environmental applications.



Farmington, CT, USA

Intus Biosciences

Bioscience

Biologics/microbiome

Connecticut Innovations provides strategic capital and operational insight to push the frontiers of high-tech industries such as energy, biotechnology, information technology, and photonics. Over the years, CI has helped over 100 emerging companies research, develop, and market new products and services. This activity has attracted over $1 billion dollars in additional investments from private equity providers. CI has brought the State of Connecticut over $510 million in Gross State Profit and over 5,000 additional job-years.

Career Opportunities